Type B insulin resistance syndrome associated with an immune reconstitution inflammatory syndrome in an HIV-infected woman

Kamel Mohammedi, Ronan Roussel, Oussaima El Dbouni, Louis Potier, Charbel Abi Khalil, Emilie Capel, Corinne Vigouroux, Martine Caron-Debarle, Jacqueline Capeau, Michel Marre

Research output: Contribution to journalArticle

8 Citations (Scopus)

Abstract

Context: Type B insulin resistance syndrome is a rare condition characterized by the presence of autoantibodies directed against the insulin receptor. It has been reported in association with autoimmune diseases such as systemic lupus erythematosus. Objective: We report a case of type B insulin resistance syndrome in a patient with HIV infection on highly active antiretroviral therapy (HAART). Patient and Methods: A 27-yr-old African woman with ketosis-prone diabetes and HIV infection developed severe insulin resistance after the initiation of HAART. Standard oral glucose tolerance tests using 75 g of glucose performed 1, 2, and 3 months after the initiation of HAART showed severe hyperinsulinemia and hypoglycemia. Six months later, she developed symptomatic hyperglycemia resistant to high-dose insulin therapy. To determine the cause of insulin resistance, we assayed the titer of insulin receptor autoantibodies in the serum of the patient. Results: Plasma insulin receptor autoantibodies were present at the time of marked hyperglycemia and insulin resistance, confirming the diagnosis of type B insulin resistance syndrome. Simultaneously the diagnosis of immune reconstitution inflammatory syndrome was established according to increased CD4 T cell count, decreased plasma HIV1-RNA level, and tuberculosis reactivation, shortly after institution of HAART. Corticosteroid therapy improved insulin resistance and hyperglycemia. Conclusion: We report the first case of type B insulin resistance syndrome associated with immune reconstitution inflammatory syndrome in an HIV-infected patient.

Original languageEnglish
JournalJournal of Clinical Endocrinology and Metabolism
Volume96
Issue number4
DOIs
Publication statusPublished - Apr 2011
Externally publishedYes

Fingerprint

Immune Reconstitution Inflammatory Syndrome
Insulin Resistance
HIV
Insulin
Insulin Receptor
Autoantibodies
Highly Active Antiretroviral Therapy
Hyperglycemia
Plasmas
Glucose
T-cells
HIV Infections
Medical problems
Adrenal Cortex Hormones
Ketosis
B-insulin
RNA
Hyperinsulinism
CD4 Lymphocyte Count
Glucose Tolerance Test

ASJC Scopus subject areas

  • Endocrinology, Diabetes and Metabolism
  • Biochemistry
  • Endocrinology
  • Clinical Biochemistry
  • Biochemistry, medical

Cite this

Type B insulin resistance syndrome associated with an immune reconstitution inflammatory syndrome in an HIV-infected woman. / Mohammedi, Kamel; Roussel, Ronan; El Dbouni, Oussaima; Potier, Louis; Abi Khalil, Charbel; Capel, Emilie; Vigouroux, Corinne; Caron-Debarle, Martine; Capeau, Jacqueline; Marre, Michel.

In: Journal of Clinical Endocrinology and Metabolism, Vol. 96, No. 4, 04.2011.

Research output: Contribution to journalArticle

Mohammedi, Kamel ; Roussel, Ronan ; El Dbouni, Oussaima ; Potier, Louis ; Abi Khalil, Charbel ; Capel, Emilie ; Vigouroux, Corinne ; Caron-Debarle, Martine ; Capeau, Jacqueline ; Marre, Michel. / Type B insulin resistance syndrome associated with an immune reconstitution inflammatory syndrome in an HIV-infected woman. In: Journal of Clinical Endocrinology and Metabolism. 2011 ; Vol. 96, No. 4.
@article{15ecdeed3e2c4e4dbc61faece34d554a,
title = "Type B insulin resistance syndrome associated with an immune reconstitution inflammatory syndrome in an HIV-infected woman",
abstract = "Context: Type B insulin resistance syndrome is a rare condition characterized by the presence of autoantibodies directed against the insulin receptor. It has been reported in association with autoimmune diseases such as systemic lupus erythematosus. Objective: We report a case of type B insulin resistance syndrome in a patient with HIV infection on highly active antiretroviral therapy (HAART). Patient and Methods: A 27-yr-old African woman with ketosis-prone diabetes and HIV infection developed severe insulin resistance after the initiation of HAART. Standard oral glucose tolerance tests using 75 g of glucose performed 1, 2, and 3 months after the initiation of HAART showed severe hyperinsulinemia and hypoglycemia. Six months later, she developed symptomatic hyperglycemia resistant to high-dose insulin therapy. To determine the cause of insulin resistance, we assayed the titer of insulin receptor autoantibodies in the serum of the patient. Results: Plasma insulin receptor autoantibodies were present at the time of marked hyperglycemia and insulin resistance, confirming the diagnosis of type B insulin resistance syndrome. Simultaneously the diagnosis of immune reconstitution inflammatory syndrome was established according to increased CD4 T cell count, decreased plasma HIV1-RNA level, and tuberculosis reactivation, shortly after institution of HAART. Corticosteroid therapy improved insulin resistance and hyperglycemia. Conclusion: We report the first case of type B insulin resistance syndrome associated with immune reconstitution inflammatory syndrome in an HIV-infected patient.",
author = "Kamel Mohammedi and Ronan Roussel and {El Dbouni}, Oussaima and Louis Potier and {Abi Khalil}, Charbel and Emilie Capel and Corinne Vigouroux and Martine Caron-Debarle and Jacqueline Capeau and Michel Marre",
year = "2011",
month = "4",
doi = "10.1210/jc.2010-1949",
language = "English",
volume = "96",
journal = "Journal of Clinical Endocrinology and Metabolism",
issn = "0021-972X",
publisher = "The Endocrine Society",
number = "4",

}

TY - JOUR

T1 - Type B insulin resistance syndrome associated with an immune reconstitution inflammatory syndrome in an HIV-infected woman

AU - Mohammedi, Kamel

AU - Roussel, Ronan

AU - El Dbouni, Oussaima

AU - Potier, Louis

AU - Abi Khalil, Charbel

AU - Capel, Emilie

AU - Vigouroux, Corinne

AU - Caron-Debarle, Martine

AU - Capeau, Jacqueline

AU - Marre, Michel

PY - 2011/4

Y1 - 2011/4

N2 - Context: Type B insulin resistance syndrome is a rare condition characterized by the presence of autoantibodies directed against the insulin receptor. It has been reported in association with autoimmune diseases such as systemic lupus erythematosus. Objective: We report a case of type B insulin resistance syndrome in a patient with HIV infection on highly active antiretroviral therapy (HAART). Patient and Methods: A 27-yr-old African woman with ketosis-prone diabetes and HIV infection developed severe insulin resistance after the initiation of HAART. Standard oral glucose tolerance tests using 75 g of glucose performed 1, 2, and 3 months after the initiation of HAART showed severe hyperinsulinemia and hypoglycemia. Six months later, she developed symptomatic hyperglycemia resistant to high-dose insulin therapy. To determine the cause of insulin resistance, we assayed the titer of insulin receptor autoantibodies in the serum of the patient. Results: Plasma insulin receptor autoantibodies were present at the time of marked hyperglycemia and insulin resistance, confirming the diagnosis of type B insulin resistance syndrome. Simultaneously the diagnosis of immune reconstitution inflammatory syndrome was established according to increased CD4 T cell count, decreased plasma HIV1-RNA level, and tuberculosis reactivation, shortly after institution of HAART. Corticosteroid therapy improved insulin resistance and hyperglycemia. Conclusion: We report the first case of type B insulin resistance syndrome associated with immune reconstitution inflammatory syndrome in an HIV-infected patient.

AB - Context: Type B insulin resistance syndrome is a rare condition characterized by the presence of autoantibodies directed against the insulin receptor. It has been reported in association with autoimmune diseases such as systemic lupus erythematosus. Objective: We report a case of type B insulin resistance syndrome in a patient with HIV infection on highly active antiretroviral therapy (HAART). Patient and Methods: A 27-yr-old African woman with ketosis-prone diabetes and HIV infection developed severe insulin resistance after the initiation of HAART. Standard oral glucose tolerance tests using 75 g of glucose performed 1, 2, and 3 months after the initiation of HAART showed severe hyperinsulinemia and hypoglycemia. Six months later, she developed symptomatic hyperglycemia resistant to high-dose insulin therapy. To determine the cause of insulin resistance, we assayed the titer of insulin receptor autoantibodies in the serum of the patient. Results: Plasma insulin receptor autoantibodies were present at the time of marked hyperglycemia and insulin resistance, confirming the diagnosis of type B insulin resistance syndrome. Simultaneously the diagnosis of immune reconstitution inflammatory syndrome was established according to increased CD4 T cell count, decreased plasma HIV1-RNA level, and tuberculosis reactivation, shortly after institution of HAART. Corticosteroid therapy improved insulin resistance and hyperglycemia. Conclusion: We report the first case of type B insulin resistance syndrome associated with immune reconstitution inflammatory syndrome in an HIV-infected patient.

UR - http://www.scopus.com/inward/record.url?scp=79953870590&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=79953870590&partnerID=8YFLogxK

U2 - 10.1210/jc.2010-1949

DO - 10.1210/jc.2010-1949

M3 - Article

VL - 96

JO - Journal of Clinical Endocrinology and Metabolism

JF - Journal of Clinical Endocrinology and Metabolism

SN - 0021-972X

IS - 4

ER -